Competition

Corporate / M&A

Employment and Executive Compensation

IP / IT

Oerlikon

On December 16, 2022, OC Oerlikon Corporation AG, Pfäffikon (SIX: OERL), a global innovation powerhouse for surface engineering, polymer processing and additive manufacturing, announced that it has signed a definitive agreement to acquire Riri, a leading provider of coated metal accessories for the luxury fashion industry.
The transaction marks a milestone in Oerlikon’s growth strategy and diversifies Surface Solutions’ offerings and market access. The transaction is expected to close in the first quarter 2023, subject to regulatory approvals and standard closing conditions.
Homburger acts as transaction counsel to Oerlikon. The Homburger team advising Oerlikon is led by Daniel Hasler and comprises Karin Mattle, Francesco Bernasconi, Mike Lerchmüller, Julien Di Sabato (all Corporate / M&amp;A), Pietro Meineri (Litigation), Philippe Baumann (IP / IT), Dieter Grünblatt and Peter Müller (both Tax), Richard Stäuber and Daniel Lütolf (both Competition), and Giulia Menegon and Giovanni Dazio (both Employment and Executive Compensation).

Homburger advised OC Oerlikon on the acquisition of Riri 

Capital Markets

Financing and Investment Products

Financial Market Regulation

Meyer Burger

On November 11, 2022, Meyer Burger Technology AG (SIX: MBTN) (Meyer Burger) announced that it had successfully closed a rights offering, raising gross proceeds of CHF 250 m. As part of the transaction, existing shareholders of Meyer Burger were offered rights to subscribe for new shares at an offer price of CHF 0.267 per new share. New shares in respect of which subscription rights had not been exercised were placed in a rump placement. With the net proceeds from the offering, Meyer Burger primarily intends to finance the planned expansion of production capacity for its photovoltaic module production in Germany and the United States.
Homburger AG acted as legal counsel to Meyer Burger on this transaction. The Homburger team was led by Dieter Gericke and Lorenzo Togni (both Corporate / M&amp;A, Equity Capital Markets) and included Estelle Piccard, Jasmin Künzle, Isabelle Cordey, Magda Aref, Urs Stürmer, Anina Preusker, Julien Di Sabato and Thomas Leu (all Corporate / M&amp;A, Equity Capital Markets) as well as Vanessa Isler and Alexander Wherlock (both Financial Services, Capital Markets). Tax advice was rendered by Stefan Oesterhelt and Raphaël Fellay (both Tax).

Homburger advised Meyer Burger Technology AG on its rights offering raising gross proceeds of CHF 250 m

Vectivio

On October 13, 2022, VectivBio Holding AG (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, announced the release of its interim data from the first five of nine patients in its ongoing Phase 2 STARS Nutrition clinical trial, the pricing of a USD 125 m underwritten offering of ordinary shares, and an amendment to its financing agreement with Kreos Capital VI (UK) Limited, including the right to receive additional warrants under certain conditions.
The underwritten offering consists of 16,700,000 ordinary shares at an offering price of USD 7.50 per share. Investors include Cowen Healthcare Investments, Driehaus Capital Management, Eventide Asset Management, LLC, Forbion&#8217;s Growth Opportunities Fund, Frazier Life Sciences, Marshall Wace, OrbiMed, Surveyor Capital (a Citadel company), TCG X, Venrock Healthcare Capital Partners and Vivo Capital, among other specialist biotech investors.
The Homburger team includes partner Andreas Müller, associates Margrit Marti and Oliver Kneubühl, and junior associate Julien Di Sabato (all Capital Markets; Corporate / M&amp;A), partner Jürg Frick, associates Simone Gloor and Stefan Bindschedler, and junior associate Thibault Sieber (all Financing and Investment Products), partner Stefan Oesterhelt and associate Kevin Müller (both Tax), and partner Luca Dal Molin (IP / IT).

Homburger advises VectivBio on its USD 125 m underwritten offering and amendment to its financing agreement with Kreos Capital

Julien
Di Sabato

Homburger advised OC Oerlikon on the acquisition of Riri

Homburger advised Meyer Burger Technology AG on its rights offering raising gross proceeds of CHF 250 m

Homburger advises VectivBio on its USD 125 m underwritten offering and amendment to its financing agreement with Kreos Capital

Join the Team

Julien Di Sabato

Career

Languages

Bar Registration

Teams

JulienDi Sabato

Homburger advised OC Oerlikon on the acquisition of Riri

Homburger advised Meyer Burger Technology AG on its rights offering raising gross proceeds of CHF 250 m

Homburger advises VectivBio on its USD 125 m underwritten offering and amendment to its financing agreement with Kreos Capital

Join the Team

Julien Di Sabato

Career

Languages

Bar Registration

Teams

Julien
Di Sabato